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Abstract
The association between visit-to-visit systolic blood pressure variability and cardio-
vascular events has recently received a lot of attention in the cardiovascular literature.
But blood pressure variability is usually estimated on a person-by-person basis, and is
therefore subject to considerable measurement error. We demonstrate that hazard ra-
tios estimated using this approach are subject to bias due to regression dilution and we
propose alternative methods to reduce this bias: a two-stage method and a joint model.
For the two-stage method, in stage one repeated measurements are modelled using a
mixed effects model with a random component on the residual standard deviation. The
mixed effects model is used to estimate the blood pressure standard deviation for each
individual, which in stage two is used as a covariate in a time-to-event model. For
the joint model, the mixed effects sub-model and time-to-event sub-model are fitted
simultaneously using shared random effects. We illustrate the methods using data from
the Atherosclerosis Risk in Communities (ARIC) study.
Key Words: repeated measurements; mixed effects model; heteroscedasticity; survival
analysis; joint model; cardiovascular disease.
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1 Introduction
Systolic blood pressure (SBP) is universally recognised as an important risk factor for car-
diovascular disease (CVD) and is routinely included in risk scores for CVD risk prediction
[3, 8]. The prognostic value of SBP is primarily based on the mean of measurements over
multiple outpatient visits, whereas substantially less attention has been given to the vari-
ability of SBP across visits (i.e., visit-to-visit SBP variability). However, there is increasing
evidence of associations between greater visit-to-visit SBP variability and CVD outcomes in
community-based and clinical settings [11, 13, 16, 17]. Therefore, in addition to assessing
mean clinic SBP levels over time, measurements of visit-to-visit SBP variability may improve
the accuracy of CVD risk prediction, which is crucial for the optimization of patient care.
The standard deviation (SD), coefficient of variation (CV), average real variability (ARV),
and SBP variability independent of the mean (VIM) across multiple visits have been widely
used to quantify visit-to-visit SBP variability [11, 13, 16, 17, 25]. However, these measures
are estimated on a person-by-person basis, and are therefore subject to considerable mea-
surement error. This measurement error causes regression dilution bias in the estimated
association between visit-to-visit SBP variability and CVD [9].
Mixed effects models have been proposed which allow the within-individual variability to
differ between individuals. For example, Hedeker et al. introduced the mixed location scale
model, where the within-individual variances may be assumed to depend on an additional
random effect, as well as time-constant and time-varying covariates [6, 7]. More recently
Goldstein et al. have explored the mixed location scale model using a Bayesian framework
in the context of growth curve models[4].
We consider extensions of the mixed location scale model to estimate the association of
SBP variability with CVD. Repeated SBP measurements are modelled using a mixed effects
model with a random component on the within-individual standard deviation, thus allowing
the borrowing of information across individuals. The model allows for each individual to
have different within-individual variation, which describes the variability in their SBP mea-
surements. We propose two methods for estimating the association of this SBP variability
with CVD. The first is a two-stage method, where in stage one we obtain estimates of the
usual level of SBP and the SBP variability for each individual from the mixed effects model,
and in stage two these are included as covariates in a survival model for the time to the first
CVD event. The second method is a joint model where the repeated SBP measurements and
the time to first CVD event are modelled simultaneously using shared random effects [15].
There are advantages and disadvantages in the use of two-stage versus joint models.
The heavy computational burden associated with simultaneous analysis of repeated mea-
surements and time-to-event data makes the two-stage method a more feasible option for
large data sets. The two-stage method could also be readily incorporated into a landmark-
ing approach for dynamic risk prediction [23], for example in the dynamic model for CVD
risk prediction recently proposed by Paige et al [12]. However, two-stage methods for the
analysis of repeated measurements and time-to-event data have been shown to lead to bias
in estimated covariate effects compared to joint models [21]. This bias is due to two factors:
(1) regression dilution bias caused by residual measurement error in the estimates of ran-
dom effects from the mixed effects model and (2) bias caused by informative truncation of
the repeated measurements by the event of interest. In the two-stage approach this second
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source of bias can be removed by separating longitudinal follow-up from survival follow-up
if data allows, as we describe in section 2.
The outline of the paper is as follows. In section 2 we describe the methods, including the
naive method that has predominantly been used in the CVD literature, and our proposed
two-stage and joint model methods. In section 3 we compare the methods using simulation
studies and explore the accuracy of all methods in a variety of scenarios. We apply the
two-stage and joint models to data from the Atherosclerosis Risk in Communities (ARIC)
Study in section 4, and we present a final discussion in section 5.
2 Methods
The association of SBP with CVD has previously been investigated using mixed effects mod-
els to analyse repeated measurements of SBP [20, 1, 24]. In this section we first present the
naive methods for estimating SBP variability that have been commonly used in the litera-
ture, and then explore how the mixed effects model can be extended to allow SBP variability
to differ between individuals. We propose a two-stage method and a joint modelling method
for estimating the association between SBP variability and CVD events. Although we focus
here on the association between SBP variability and CVD, the methods and results pre-
sented would be relevant for any application where the association between the variability
in a longitudinal outcome and a time-to-event is of interest. We consider estimating the as-
sociation of the variability of a longitudinal outcome with a time-to-event, adjusted for the
‘usual level’ of the longitudinal outcome. This ‘usual level’ could be the average value, which
may be assumed constant in time, or the current value or baseline value if time-dependence
is to be taken into account.
2.1 Notation
Given a data set with N individuals and ni SBP measurements from the ith individual, i =
1, . . . , N , let Yij, j = 1, . . . , ni, be the jth measurement of individual i taken at measurement
time tij. Each individual is followed up from baseline until time T
∗
i = min(Ti, Ci), where Ti
is the time of the event for individual i and Ci is the censoring time.
2.2 Estimating longitudinal variability
2.2.1 Naive method
In the cardiovascular literature the usual level of SBP is typically estimated as the mean of
an individual’s repeated measurements,
BˆP
naive
i =
∑
j Yij
ni
and the SBP variability as their standard deviation
̂BPSDnaivei =
√∑
j(BˆP
naive
i − Yij)2
ni
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The repeated measurements may have been taken prior to follow-up of the time-to-event,
or concurrent with the time-to-event follow-up, in which case the repeated measurement
process is terminated by an event. Other measures of visit-to-visit SBP variability have been
proposed, such as the coefficient of variation (defined as the SD/mean), the maximum and
minimum difference and the average real variability (defined as the average change between
successive visits) [25], but all are usually estimated using within-individual information only.
2.2.2 Mixed effects models
An alternative method to estimate the usual level and variability for each individual is to
use a mixed effects model for the repeated measurements from all individuals, allowing infor-
mation to be borrowed across individuals. The mixed effects model also allows longitudinal
trajectories to be modelled by including time-dependent terms in the model.
Consider a standard linear mixed effects model,
Yij = β
TXij + b
T
i Zij + ij , (1)
where Xij is a covariate vector for the fixed effects β and Zij is a covariate vector for the
random effects bi, assumed normally distributed bi ∼ N(0,Σb). The residual errors ij are
assumed independent and normally distributed, ij ∼ N(0, σ2). We can allow variability
in the repeated measurements to differ between individuals by replacing the residual stan-
dard deviation (SD) σ with an individual-specific residual SD σi and assuming that the
σi are randomly distributed. Note that in this model we do not distinguish between true
variability in an individual’s repeated measurements and measurement error. We assume
a log-Normal distribution for the residual SD distribution, ensuring positivity of the SDs,
σi ∼ logN(µσ, τ 2σ). The choice of log-Normal distribution also allows a natural extension of
the model to incorporate correlation between the usual level and the residual SD by assuming
a multivariate normal distribution for the random effects and log residual SD,
ij ∼ N(0, σ2i ) ,
(
bi
log σi
)
∼ N
((
0
µσ
)
,
(
Σb Σbσ
ΣTbσ τ
2
σ
))
, (2)
where Σbσ is a vector of covariances between the random effects and the random residual
errors. Alternative distributions have been proposed for the residual SD, such as the half-
Cauchy distribution [10]. (See also Hedeker et al [6] and recent work by Goldstein et al [4],
where a log-Normal distribution was assumed for the residual variances σ2i .)
Specific examples of the model specified by equations (1) and (2) which we will consider
are a random-intercept model
Yij = β
TXi + b0i + ij , (3)
where the random intercept b0i can be interpreted as the usual level of the repeated measure-
ments, and adjustment is made for baseline covariates Xi. We consider a model (LMM1)
which does not account for the correlation between b0i and σi,
LMM1:
(
b0i
log σi
)
∼ N
((
0
µσ
)
,
(
τ 20 0
0 τ 2σ
)
,
)
(4)
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and a model (LMM2) which does account for the correlation
LMM2:
(
b0i
log σi
)
∼ N
((
0
µσ
)
,
(
τ 20 ρτ0τσ
ρτ0τσ τ
2
σ
)
.
)
(5)
We also consider a random intercept and slope model
Yij = Xiβ + βttij + b0i + b1itij + ij ,
where the random intercept b0i is now the baseline value (minus the population average),
and σi now measures the variability around the individual’s average trajectory. Again, we
can either ignore or allow for correlations between the random effects and the residual SD’s,
LMM3:
 b0ib1i
log σi
 ∼ N
 00
µσ
 ,
 τ 20 ρ01τ0τ1 0ρ01τ0τ1 τ 21 0
0 0 τ 2σ
 ,
LMM4:
 b0ib1i
log σi
 ∼ N
 00
µσ
 ,
 τ 20 ρ01τ0τ1 ρ0στ0τσρ01τ0τ1 τ 21 ρ1στ1τσ
ρ0στ0τσ ρ1στ1τσ τ
2
σ
 .
(6)
2.3 Estimating the association between SBP variability and CVD
We consider two approaches for estimating the association between SBP variability and the
time to the first CVD event, a two-stage approach and a joint model.
2.3.1 Two-stage approach
We fit the models in two stages. In stage one we either (i) estimate the usual level and SD
of the repeated measurements for each individual using the naive method, or (ii) fit a mixed
effects model and estimate the usual level, residual SD and other random effects for each
individual, as described in section 2.2. In the second stage we use the estimated usual level
and residual SD as covariates in a standard proportional hazards Cox regression for the time
to the first event,
hi(t) = h0(t) exp(α
TUi + γ
TWi) ,
where Ui is a vector containing the estimated usual level, residual SD and other random
effects for each individual, α is a vector of parameters describing the association between the
mixed effects model and the time-to-event model and Wi is a vector of baseline covariates.
We estimate mixed effects model parameters using Bayesian MCMC implemented using
JAGS Version 3.4.0 [14] and the R2jags package in R [19]. We assume diffuse priors for
all model parameters. The usual level BˆP
LMM
i is estimated by the posterior mean of the
random intercept b0i and the variability ̂BPSDLMMi by the posterior mean of the residual
SD σi. Additional random effects can also be estimated by posterior means.
The SBP measurement process is truncated informatively by the event of interest, as
illustrated in Figure 1a. In order to avoid this informative truncation we can divide all
follow-up into follow-up of the repeated measurements and follow-up of the survival outcome,
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separated at separation time tsep, as shown in Figure 1b. Only repeated measurements taken
before tsep are used in estimation of the mixed effects model, and only events taking place
after the separation time are used in estimation of the time-to-event model conditional on
surviving until tsep. Separating the longitudinal follow-up from the survival follow-up in
this way involves discarding information from repeated measurements following tsep and
individuals experiencing events before tsep. In practice tsep should be chosen to minimise this
information loss.
2.3.2 Joint model
In the joint model we use a shared parameter approach to link the mixed effects and time-
to-event models. The mixed effect sub-model is defined by equations (1) and (2). The
time-to-event sub-model is defined by
hi(t) = h0(t) exp(α
T bi + γ
TWi) .
where bi are the random effects shared with the mixed effects sub-model. We assume a
piecewise constant baseline hazard; we choose cut-points tk, 0 ≤ k ≤ K, at the K-quantiles
of the observed event times and assume that the baseline hazard is constant in the time
intervals between cut-points, h0(t) = h0,k, tk−1 < t ≤ tk. The piecewise-constant assumption
ensures that the hazard function can be integrated analytically, thus avoiding the need for
numerical integration when evaluating the likelihood function. In practice the number of
cut-points can be chosen by assessing model fit, for example using the deviance information
criterion (DIC)[18].
We again estimate model parameters using Bayesian MCMC implemented using JAGS
Version 3.4.0 [14] and the R2jags package in R [19] and assuming diffuse priors for all model
parameters.
2.4 Regression dilution bias in association parameters
In the two-stage approach, because SBP variability is estimated with error we expect bias in
the estimated association with CVD due to regression dilution. We aim to reduce regression
dilution bias by using a mixed effects model which allows information to be borrowed across
individuals. The joint model accounts for this measurement error by including the underlying
random effects in the time-to-event model, rather than estimates of those random effects.
However, misspecification of the mixed or joint models could introduce other sources of
bias. In Section 1 of the Supplementary Materials we show for the simplified case of linear
regression that ignoring the correlation between the random effects and the residual SD could
also lead to bias in the estimated effects of both the usual level and the variability on the
outcome.
3 Simulation studies
We use simulation studies to explore the bias in parameter estimates due to imprecise esti-
mation of SBP variability, and due to ignoring correlation between SBP and SBP variability
6
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Figure 1: Diagrams illustrating the use of SBP measurements and time-to-event data when
(a) time-to-event follow-up and SBP measurement follow-up run concurrently from time t=0
and (b) repeated measurement follow-up takes place prior to time-to-event follow-up.
in the mixed effects model. We consider two scenarios. In Scenario 1 each individual has the
same number of repeated measurements, thus bias in the two-stage approaches arises solely
from measurement error in the estimates of the usual level and variability of SBP (c.f. Figure
1b). In Scenario 2 the repeated measurement process is truncated by the event times, so
that bias in the two-stage approaches arises from both measurement error and informative
truncation of the repeated measurements (c.f. Figure 1a). We generated simulated data
sets to explore the effect of the number of measurements per individual, the value of the
association parameters and the extent of the correlation between the usual level and the
variability.
We take a simple model for the repeated measurements with a random intercept only
and random residual error standard deviation
BPij = b0i + ij
where the residual error ij ∼ N(0, σ2i ) and we take a bivariate normal distribution for b0i
and log σi, (
b0i
log σi
)
∼ N
((
µ0
µσ
)
,
(
τ 20 ρτ0τσ
ρτ0τσ τ
2
σ
))
,
Here b0i is the usual level and σi represents the variability in the longitudinal outcome. Based
on results from the ARIC study, we take µ0 = 120, τ0 = 15, µσ = 2 and τσ = 0.5. Event
times are drawn from a Weibull distribution with shape parameter k and scale parameter λ.
A loglinear effect of the covariates on λ gives a proportional hazards model,
λ = exp(γ0 + α0b0i + ασσi)
We introduce administrative censoring at 20 years. To maintain an event rate of 20% before
censoring we take γ0 = −10.26 and k = 2 with default association parameters α0 = 0.02
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and ασ = 0.05, similar to those found for the ARIC data set. For Scenario 1 we used all re-
peated measurements for all individuals. For Scenario 2 we assumed repeated measurements
were taken equidistantly between baseline and 18 years follow-up and discarded all repeated
measurements following event times. In each simulation set-up we generated 1000 data sets,
each consisting of 1500 individuals.
We analysed each generated data set using the two-stage method from section 2.3.1, with
(i) naive and (ii) mixed model estimates of SBP usual levels and variabilities, and the joint
models from section 2.3.2. For the mixed effects and joint models we fitted models ignoring
the correlation between SBP and SBP variability (mixed effects model LMM1 and joint
model JM1 used equations (3) and (4)), and allowing for the correlation (mixed effects model
LMM2 and joint model JM2 used equations (3) and (5)). The joint models were fitted using
15 time intervals for the baseline hazard. Model convergence was checked using the Gelman-
Rubin statistic as modified by Brooks and Gelman [2]. We also fitted the survival models
using the true values of b0i and σi as covariates, representing the best achievable results
from the time-to-event model when all covariates are known precisely. For all scenarios we
calculated the mean and standard deviation of the estimated log hazard ratios and the root
mean squared errors (RMSE) and coverage probabilities at the 95% level.
Table 1 shows results for n = 4, n = 7 and n = 10 measurements per individual for
Scenario 1. With 4 measurements per individual using the naive method leads to a slight
bias in the log hazard ratio (logHR) for the usual level, but substantial negative bias and
associated loss of coverage in the logHR for variability, which is most likely caused by re-
gression dilution due to imprecise measurement of longitudinal variability. Using the mixed
effects model LMM1 leads to a positive bias in both the usual level logHR and the variabil-
ity logHR, as we would expect from the arguments given in Section1 of the Supplementary
Materials, because correlation between these quantities was not accounted for in their esti-
mation. Using method LMM2, which accounts for the correlation, results in minimal bias,
even with only 4 measurements per individual. For both two-stage models the coverage is
a little below the nominal level, but the RMSE is larger for the variability logHR in LMM2
due to greater variation in effect estimates. Results for the joint models are similar to the
two-stage models in terms of the bias, but coverage is closer to the nominal levels. Results
for n=7 and n=10 are similar, with the naive model giving reduced but still substantial bias
in the variability logHR with a greater number of measurements.
Table 2 shows results for n = 4, n = 7 and n = 10 measurements per individual for
Scenario 2. The two-stage model LMM2 now also gives negative bias in estimating the
variability logHR due to informative truncation of the repeated measurements by the CVD
event. The joint model JM2, which accounts for this informative truncation, gives consistent
results. Our results suggest that the bias incurred in the two-stage approach by informative
truncation is more considerable here than the bias incurred by error in the estimates of SBP
variability from the LMM models.
In Section 2 of the Supplementary Materials we present further results investigating per-
formance of the models for different levels of association between the longitudinal trajectories
and the CVD event (Supplementary Table 1) and for different levels of correlation between
the usual level and the variability (Supplementary Table 2). All results are given for datasets
with n = 4 measurements. In brief, all methods performed well with no association between
times-to-events and longitudinal variability. But when the associations between the time-
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Table 1: Scenario 1 results with different numbers of repeated measurements. Presented are the true values, mean (standard
deviation) of estimated log hazard ratios, root mean squared error and coverage over 1000 simulated datasets. Methods of
analysis are (1) True values, where the true usual levels and variabilities are used as covariates, (2) Naive method, (3) LMM1,
the two-stage approach with no correlation between the usual level and the variability, (4) LMM2, the two-stage approach with
correlation, (5) JM1, the joint model with no correlation and (6) JM2, the joint model with correlation.
Usual level logHR α0 Variability logHR ασ
True Mean (SD) RMSE Coverage True Mean (SD) RMSE Coverage
n=4
True values 0.02 0.02 (0.0043) 0.0043 0.94 0.05 0.0501 (0.0117) 0.0117 0.94
Naive 0.02 0.0208 (0.0037) 0.0038 0.947 0.05 0.0284 (0.0094) 0.0235 0.31
LMM1 0.02 0.0227 (0.0042) 0.005 0.892 0.05 0.0531 (0.0151) 0.0154 0.929
LMM2 0.02 0.0198 (0.0049) 0.0049 0.948 0.05 0.0511 (0.0175) 0.0175 0.931
JM1 0.02 0.023 (0.0042) 0.0052 0.883 0.05 0.0521 (0.0155) 0.0156 0.939
JM2 0.02 0.02 (0.0051) 0.0051 0.949 0.05 0.0502 (0.0183) 0.0183 0.936
n=7
True values 0.02 0.0202 (0.0042) 0.0042 0.946 0.05 0.0496 (0.0113) 0.0113 0.951
Naive 0.02 0.0209 (0.0039) 0.004 0.943 0.05 0.0354 (0.01) 0.0177 0.684
LMM1 0.02 0.022 (0.0042) 0.0047 0.913 0.05 0.0519 (0.0133) 0.0134 0.943
LMM2 0.02 0.0202 (0.0046) 0.0046 0.95 0.05 0.0502 (0.0146) 0.0146 0.944
JM1 0.02 0.0221 (0.0042) 0.0048 0.91 0.05 0.0509 (0.0135) 0.0136 0.952
JM2 0.02 0.0203 (0.0047) 0.0047 0.945 0.05 0.0493 (0.015) 0.015 0.946
n=10
True values 0.02 0.0199 (0.0041) 0.0041 0.953 0.05 0.05 (0.0111) 0.0111 0.956
Naive 0.02 0.0206 (0.004) 0.004 0.948 0.05 0.039 (0.0102) 0.015 0.818
LMM1 0.02 0.0212 (0.0042) 0.0044 0.938 0.05 0.0516 (0.0124) 0.0125 0.95
LMM2 0.02 0.0199 (0.0045) 0.0045 0.944 0.05 0.0501 (0.0134) 0.0134 0.95
JM1 0.02 0.0213 (0.0042) 0.0044 0.931 0.05 0.0508 (0.0125) 0.0125 0.956
JM2 0.02 0.02 (0.0045) 0.0045 0.943 0.05 0.0494 (0.0136) 0.0136 0.946
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Table 2: Scenario 2 results with different numbers of repeated measurements. Presented are the true values, mean (standard
deviation) of estimated log hazard ratios, root mean squared error and coverage over 1000 simulated datasets. Methods of
analysis are (1) True values, where the true usual levels and variabilities are used as covariates, (2) Naive method, (3) LMM1,
the two-stage approach with no correlation between the usual level and the variability, (4) LMM2, the two-stage approach with
correlation, (5) JM1, the joint model with no correlation and (6) JM2, the joint model with correlation.
Usual level logHR α0 Variability logHR ασ
True Mean (SD) RMSE Coverage True Mean (SD) RMSE Coverage
n=4
True values 0.02 0.02 (0.0042) 0.0042 0.938 0.05 0.0496 (0.0115) 0.0115 0.942
Naive 0.02 0.0229 (0.0041) 0.005 0.86 0.05 0.0118 (0.0122) 0.0401 0.036
LMM1 0.02 0.0229 (0.0042) 0.0051 0.892 0.05 0.0348 (0.0153) 0.0216 0.868
LMM2 0.02 0.0203 (0.0047) 0.0047 0.952 0.05 0.0385 (0.0166) 0.0202 0.934
JM1 0.02 0.0236 (0.0047) 0.0059 0.852 0.05 0.0409 (0.0211) 0.0229 0.908
JM2 0.02 0.0199 (0.0055) 0.0055 0.94 0.05 0.0493 (0.022) 0.022 0.944
n=7
True values 0.02 0.0203 (0.004) 0.0041 0.96 0.05 0.0498 (0.011) 0.011 0.964
Naive 0.02 0.0225 (0.0039) 0.0047 0.89 0.05 0.0242 (0.011) 0.028 0.28
LMM1 0.02 0.0221 (0.004) 0.0045 0.92 0.05 0.0418 (0.0126) 0.015 0.928
LMM2 0.02 0.0205 (0.0042) 0.0042 0.96 0.05 0.0437 (0.0133) 0.0147 0.96
JM1 0.02 0.0223 (0.0043) 0.0049 0.904 0.05 0.0466 (0.0153) 0.0157 0.952
JM2 0.02 0.0202 (0.0046) 0.0046 0.952 0.05 0.0502 (0.0156) 0.0156 0.968
n=10
True values 0.02 0.0203 (0.0041) 0.0041 0.954 0.05 0.0506 (0.012) 0.012 0.938
Naive 0.02 0.0222 (0.004) 0.0045 0.902 0.05 0.031 (0.0121) 0.0226 0.544
LMM1 0.02 0.0216 (0.004) 0.0043 0.93 0.05 0.0449 (0.0136) 0.0145 0.918
LMM2 0.02 0.0205 (0.0042) 0.0042 0.958 0.05 0.0458 (0.0139) 0.0145 0.94
JM1 0.02 0.0216 (0.0043) 0.0045 0.926 0.05 0.0487 (0.0155) 0.0155 0.918
JM2 0.02 0.0202 (0.0045) 0.0045 0.956 0.05 0.0506 (0.0159) 0.0159 0.932
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to-event and the usual level and variability of the longitudinal trajectories was substantially
stronger, all the methods struggled to give consistent results with only 4 repeated measure-
ments. The joint models performed the best in this case with the least bias and highest
coverage (Supplementary Table 1). When there is negative correlation between usual levels
and variabilities the direction of bias is reversed. Bias in the usual level logHR using methods
LMM1 and JM1 increases with increasing ρ. But for the variability logHR the pattern is
less clear because of the interplay between regression dilution bias and the bias incurred by
ignoring correlation in the mixed effects model (Supplementary Table 2).
In summary, the method which overall resulted in the least bias was JM2. For parameter
values similar to those observed in the data example method LMM2 performed well. But
for all methods biases were observed with strong association parameters with n = 4 mea-
surements per individual, so more measurements per individual would be required in this
scenario. The interplay between biases due to multiple causes is complex, and depends on
the correlation parameter ρ. The RMSE, however, is generally slightly higher for LMM2
than for LMM1 and for JM2 than for JM1, suggesting a trade-off between the bias caused
by ignoring the correlation for models LMM1 and JM1 and the higher variance induced by
the increased complexity of models LMM2 and JM2.
4 Example: ARIC study
We illustrate our methods using data from the ARIC study [22]. Briefly, 15,792 mostly
black and white adults aged 45-64 years were enrolled into the ARIC study between 1987
and 1989 via probability sampling from 4 U.S. communities: Washington County, Maryland;
Forsyth County, North Carolina; Minneapolis, Minnesota, suburbs; and Jackson, Mississippi.
Participants underwent five examinations during 25-years of follow-up (i.e., Visit 1, 2, 3, 4,
and 5 examinations), with an annual contact by telephone. In the current analysis, we used
SBP measurements from Visit 1 (1987-1989) through Visit 4 (1996-1998).
We analysed both the full ARIC dataset and a reduced dataset where longitudinal follow-
up was truncated at the last systolic SBP measurement taken at Visit 4 (at tsep = 11.9
years from baseline) and the time origin for the survival follow-up was taken at the same
time-point (Figure 1b). For the reduced dataset, to have enough measurements to estimate
the standard deviation of repeated measurements using the naive method we restricted to
individuals with three or four non-missing measurements recorded and also to individuals
who did not experience an event before tsep. In total, our full data set consisted of 13,161
individuals and our reduced data set consisted of 10,019 individuals. Supplementary Table
3 shows the baseline characteristics of the reduced and full datasets.
We analysed both the full and reduced data-sets using two-stage and joint models. For
the two-stage approaches we used the repeated measurements of SBP to estimate the usual
SBP level and the SBP variability using the naive method and the linear mixed effects
models without and with accounting for the correlation between SBP and SBP variability
(we again label these models LMM1 and LMM2 respectively). We also fitted joint models
both without and with correlation between SBP and SBP variability (again JM1 and JM2
respectively). We applied the mixed effects models/sub-models in four ways
1. With a random intercept only, not adjusting for baseline CVD risk factors
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Figure 2: Histograms of the distribution of (a) naive usual SBP estimates and (b) naive
SBP variability estimates in data from the ARIC study. Also plotted are probability density
functions of (a) a normal distribution fitted to the data and (b) a log-normal distribution
fitted to the data.
2. Including a slope term in the model as both a fixed and random effect. The covariance
matrix between the random effects and the residual log-standard deviation was taken to
be unstructured, allowing for correlations between the random slopes and the random
intercept and between the random slopes and the SBP variability.
3. Adjusting the random intercept mixed effects model for baseline CVD risk factors
(age, sex, diabetes status, smoking status, baseline total cholesterol and baseline HDL
cholesterol)
4. Adjusting the random intercept and slope mixed effects model for baseline CVD risk
factors.
Time-to-event models were adjusted for age, diabetes status, smoking status, baseline total
cholesterol, baseline HDL cholesterol and sex.
For the Bayesian estimation we used diffuse uniform prior distributions U [0, 100] for
standard deviations, uniform U [−1, 1] prior distributions for correlation parameters and
diffuse normal prior distributions N(0, 1002) for all other parameters. Priors were specified
for the bivariate and trivariate normal distributions by expressing them as two and three
conditional univariate normal distributions respectively. We used a burn-in of 1000 MCMC
updates for the mixed effects models and 2000 MCMC updates for the joint models. We
calculated results from 1000 sampled updates, and checked convergence using the Gelman-
Rubin statistic as modified by Brooks and Gelman [2]. For the joint models there was a high
degree of auto-correlation for the usual SBP and SBP variability hazard ratios, so MCMC
chains were thinned by 4 updates.
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Figure 3: Scatter plot of log naive SBP variability estimates against naive SBP usual level
estimates with a fitted regression line.
Figure 2 shows histograms of the estimated SBP usual level and SBP variability using the
naive method. Also plotted are fitted normal and log-normal distributions respectively. The
plots suggest that the assumption of a normal distribution for the random intercepts and a
log-normal distribution for the residual SDs is appropriate. The naive usual level estimates
are plotted against the naive variability estimates in Figure 3. There is a positive correlation
with those with higher SBP tending to have greater SBP variability. The correlation between
the naive estimates is 0.42, but the true correlation without measurement error is likely to
be higher.
Estimates of usual levels and variabilities from the mixed effects models are compared
with the naive estimates in Figure 4. The plotted lines are the lines of agreement between
the two methods. Note that there is more difference between the methods for SBP variability
estimates than for usual level estimates, with lower SBP variabilities being underestimated
by the naive method and higher variabilities being overestimated.
Results from all models applied to the reduced ARIC data set are shown in table 3. As
expected, the joint models took considerably longer to run than the two-stage models with
runtimes of between 17 and 20 hours compared to between 4 and 10 minutes respectively.
All methods find an increased risk of CVD events with higher SBP variability. The methods
which include random slopes find no evidence for an association between SBP gradient and
CVD risk after adjusting for the usual level of SBP and SBP variability.
The estimated association of SBP variability with CVD events is smaller for the naive
model, suggesting regression dilution bias in this parameter estimate. Method LMM1, which
does not account for the correlation between the SBP usual level and variability, gives a
higher estimate of the association with the usual level of SBP than method LMM2, which
does account for the correlation, as would be expected from the arguments given in Section
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Figure 4: Scatter plots of estimates using the LMM2 method against estimates using the
naive method of (a) SBP usual level and (b) SBP variability with lines of agreement between
the two estimates.
1 of the Supplementary Materials. The estimate of the association with SBP variability is
generally lower for LMM2 than LMM1, suggesting a slight bias in the LMM1 estimates.
The standard errors are, however, considerably larger for LMM2 than for LMM1. There is
little difference between the results from the joint models and the results from the two-stage
LMM models. Adjusting for other CVD risk factors in the mixed effects model makes little
difference to the estimated association with SBP usual level and variability.
Results from all models applied to the full ARIC data set are shown in table 4. For the
models without random slopes the logHRs for the SBP usual level and SBP variability are
similar to those from the truncated dataset. Standard errors are slightly smaller reflecting
the increased sample size. But for the models with random slopes the logHRs for the effect
of slope on the hazard of CVD are very different for the full dataset, with more positive
slopes now leading to a lower risk of a CVD event when adjusted for the SBP usual level
and SBP variability. This is counterintuitive to what we would expect; as higher SBP is
associated with greater risk of CVD we would expect those with increasing SBP over time
to also have a higher risk.
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Table 3: Results (logHRs with standard errors in brackets) from all models applied to reduced data from the ARIC study. Methods LMM1, LMM2,
LMM3 and LMM4 are two-stage methods respectively with (1) random intercept only and no correlation between the random intercept and the
variability, (2) random intercept only and correlation, (3) random intercepts and slopes and no correlation between the random effects and the
variability, (4) random intercepts and slopes and correlation. JM1, JM2, JM3 and JM4 are the corresponding joint models. Adjusted LMM’s adjust
the longitudinal models/sub-models for baseline CVD risk factors.
Model Usual level α1 Variability ασ Slope α3 Total chol. HDL chol. Age Smoker Diabetic Male sex
Naive Model
0.019 (0.002) 0.017 (0.005) 0.114 (0.029) -0.369 (0.085) 0.072 (0.006) -0.503 (0.069) -0.67 (0.084) 0.273 (0.067)
Unadjusted LMM
LMM1 0.023 (0.003) 0.045 (0.011) 0.113 (0.029) -0.37 (0.085) 0.072 (0.006) -0.505 (0.069) -0.671 (0.084) 0.273 (0.067)
LMM2 0.015 (0.006) 0.053 (0.021) 0.113 (0.029) -0.37 (0.085) 0.072 (0.006) -0.506 (0.069) -0.668 (0.084) 0.272 (0.067)
JM1 0.023 (0.003) 0.045 (0.011) 0.114 (0.029) -0.380 (0.087) 0.072 (0.006) -0.498 (0.068) -0.670 (0.086) 0.274 (0.065)
JM2 0.014 (0.007) 0.058 (0.023) 0.114 (0.029) -0.371 (0.085) 0.073 (0.006) -0.503 (0.070) -0.657 (0.081) 0.277 (0.068)
Adjusted LMM
LMM1 0.023 (0.003) 0.047 (0.011) 0.129 (0.029) -0.405 (0.085) 0.084 (0.006) -0.447 (0.068) -0.754 (0.083) 0.297 (0.067)
LMM2 0.012 (0.007) 0.062 (0.022) 0.125 (0.029) -0.402 (0.085) 0.081 (0.006) -0.437 (0.068) -0.749 (0.083) 0.313 (0.067)
JM1 0.023 (0.003) 0.045 (0.012) 0.129 (0.028) -0.408 (0.085) 0.085 (0.006) -0.452 (0.066) -0.766 (0.085) 0.297 (0.069)
JM2 0.010 (0.007) 0.071 (0.023) 0.127 (0.028) -0.404 (0.084) 0.081 (0.006) -0.440 (0.070) -0.754 (0.090) 0.318 (0.069)
Unadjusted LMM with slope
LMM3 0.023 (0.003) 0.047 (0.009) 0.024 (0.074) 0.112 (0.029) -0.37 (0.085) 0.072 (0.006) -0.507 (0.069) -0.657 (0.084) 0.264 (0.067)
LMM4 0.016 (0.006) 0.053 (0.018) 0.01 (0.089) 0.113 (0.029) -0.371 (0.085) 0.072 (0.006) -0.507 (0.069) -0.657 (0.084) 0.263 (0.067)
JM3 0.023 (0.003) 0.047 (0.011) 0.020 (0.077) 0.114 (0.027) -0.370 (0.086) 0.073 (0.006) -0.517 (0.072) -0.659 0.088 0.265 (0.069)
JM4 0.015 (0.005) 0.056 (0.015) 0.004 (0.089) 0.114 (0.029) -0.374 (0.087) 0.072 (0.006) -0.512 (0.069) -0.662 (0.085) 0.265 (0.068)
Adjusted LMM with slope
LMM3 0.022 (0.003) 0.049 (0.009) 0.033 (0.071) 0.129 (0.029) -0.403 (0.085) 0.084 (0.006) -0.442 (0.068) -0.747 (0.084) 0.296 (0.067)
LMM4 0.014 (0.006) 0.057 (0.017) 0.006 (0.085) 0.124 (0.029) -0.406 (0.085) 0.081 (0.006) -0.437 (0.068) -0.723 (0.084) 0.303 (0.067)
JM3 0.023 (0.003) 0.049 (0.010) 0.021 (0.071) 0.130 (0.029) -0.408 (0.085) 0.084 (0.006) -0.458 (0.067) -0.766 (0.082) 0.292 (0.067)
JM4 0.014 (0.006) 0.060 (0.017) -0.003 (0.101) 0.126 (0.029) -0.406 (0.083) 0.081 (0.006) -0.441 (0.067) -0.744 (0.081) 0.304 (0.067)
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Table 4: Results (logHRs with standard errors in brackets) from all models applied to full data from the ARIC study. Methods LMM1, LMM2,
LMM3 and LMM4 are two-stage methods respectively with (1) random intercept only and no correlation between the random intercept and the
variability, (2) random intercept only and correlation, (3) random intercepts and slopes and no correlation between the random effects and the
variability, (4) random intercepts and slopes and correlation. JM1, JM2, JM3 and JM4 are the corresponding joint models. Adjusted LMM’s adjust
the longitudinal models/sub-models for baseline CVD risk factors.
Model Usual level α1 Variability ασ Slope α3 Total chol. HDL chol. Age Smoker Diabetic Male sex
Naive Model
0.02 (0.001) 0.016 (0.003) 0.118 (0.02) -0.461 (0.061) 0.06 (0.004) -0.62 (0.046) -0.8 (0.054) 0.395 (0.048)
Unadjusted LMM
LMM1 0.023 (0.002) 0.042 (0.007) 0.124 (0.019) -0.436 (0.057) 0.06 (0.004) -0.634 (0.044) -0.853 (0.051) 0.382 (0.045)
LMM2 0.015 (0.004) 0.053 (0.014) 0.124 (0.019) -0.437 (0.057) 0.06 (0.004) -0.632 (0.044) -0.849 (0.051) 0.381 (0.045)
JM1 0.024 (0.002) 0.045 (0.007) 0.126 (0.019) -0.440 (0.055) 0.060 (0.004) -0.636 (0.044) -0.855 (0.050) 0.391 (0.045)
JM2 0.012 (0.005) 0.065 (0.016) 0.125 (0.020) -0.445 (0.058) 0.061 (0.004) -0.633 (0.045) -0.862 (0.050) 0.392 (0.047)
Adjusted LMM
LMM1 0.023 (0.002) 0.043 (0.006) 0.137 (0.019) -0.453 (0.057) 0.073 (0.004) -0.59 (0.044) -0.956 (0.051) 0.409 (0.045)
LMM2 0.013 (0.004) 0.058 (0.013) 0.134 (0.019) -0.456 (0.057) 0.07 (0.004) -0.579 (0.044) -0.949 (0.051) 0.42 (0.045)
JM1 0.024 (0.002) 0.046 (0.007) 0.139 (0.019) -0.456 (0.061) 0.073 (0.004) -0.603 (0.045) -0.988 (0.051) 0.415 (0.045)
JM2 0.009 (0.005) 0.074 (0.016) 0.137 (0.020) -0.462 (0.058) 0.070 (0.004) -0.575 (0.043) -0.943 (0.050) 0.439 (0.049)
Unadjusted LMM with slope
LMM3 0.025 (0.002) 0.045 (0.006) -0.129 (0.049) 0.123 (0.019) -0.441 (0.057) 0.059 (0.004) -0.635 (0.044) -0.823 (0.051) 0.363 (0.045)
LMM4 0.02 (0.004) 0.048 (0.011) -0.212 (0.06) 0.123 (0.019) -0.442 (0.057) 0.059 (0.004) -0.632 (0.044) -0.821 (0.051) 0.359 (0.045)
JM3 0.026 (0.002) 0.049 (0.006) -0.183 (0.066) 0.125 (0.019) -0.453 (0.060) 0.060 (0.004) -0.647 (0.046) -0.845 (0.048) 0.366 (0.047)
JM4 0.018 (0.004) 0.061 (0.012) -0.302 (0.085) 0.128 (0.019) -0.458 (0.058) 0.061 (0.004) -0.646 (0.047) -0.847 (0.055) 0.374 (0.046)
Adjusted LMM with slope
LMM3 0.026 (0.002) 0.047 (0.006) -0.118 (0.051) 0.138 (0.019) -0.458 (0.057) 0.072 (0.004) -0.599 (0.044) -0.953 (0.051) 0.398 (0.045)
LMM4 0.019 (0.004) 0.051 (0.01) -0.185 (0.06) 0.132 (0.019) -0.461 (0.057) 0.069 (0.004) -0.598 (0.044) -0.96 (0.051) 0.39 (0.045)
JM3 0.027 (0.002) 0.052 (0.006) -0.163 (0.061) 0.141 (0.019) -0.469 (0.057) 0.074 (0.004) -0.608 (0.046) -0.968 (0.052) 0.405 (0.045)
JM4 0.017 (0.004) 0.065 (0.011) -0.253 (0.083) 0.136 (0.019) -0.480 (0.058) 0.070 (0.004) -0.587 (0.045) -0.939 (0.052) 0.416 (0.047)
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5 Discussion
We have proposed two-stage and joint modelling methods to estimate the association between
visit-to-visit SBP variability and CVD, both of which use extensions of standard mixed effects
models to allow different individuals to have different SBP variabilities. Both methods reduce
regression dilution bias in the estimated hazard ratio compared to naive methods that have
previously been used where SBP variability is estimated on an individual-by individual basis.
In addition, the joint modelling methods allow for informative truncation of the repeated
measurement process by the event of interest. In practice the method of choice will depend
on the likely extent of the biases incurred by the two-stage approach vs the computational
tractability of the joint modelling approach.
An important assumption of the two-stage method is that truncation of the observation
process is non-informative, otherwise the number of observations may depend on the un-
derlying risk level, which may lead to bias. Informative truncation can be avoided in the
two-stage approach if distinct periods of follow-up for longitudinal and survival data can be
defined, but this may only be possible at the cost of discarding information from individuals
with events during longitudinal follow-up and repeated measurements taken during survival
follow-up. In the clinical literature analyses have been conducted both using survival follow-
up recorded subsequently to the repeated observations of SBP and using survival follow-up
recorded concurrently with SBP measurements. As an example of the former, Rothwell et
al explored the use of 7 compared with 10 SBP measurements, but commented that when
10 SBP measurements were used survival follow-up was shorter[16].
Another important assumption of our method is that the measurement schedule is non-
informative, which will not be satisfied in some studies. Some clinical studies investigating
the association between SBP variability and CVD have used data which has not been col-
lected for research purposes, such as data from electronic health records. For example,
Gosmanova et al used data from around 3 million US veterans receiving healthcare from
the US Veterans Health Administration[5] and Hippisley-Cox et al used SBP variability as a
risk predictor in the most recent QRISK tool for predicting CVD based on around 8 million
individuals attending general practices in the UK[8]. In such cases additional bias may be
incurred by informative observation of the repeated measurements, where the act of mea-
surement is more (or less) likely in individuals at greater risk of disease. In these cases it
may be necessary to extend the joint model to include an additional sub-model for the recur-
rent event process of an SBP measurement being taken. However, for cohort studies with a
pre-specified measurement schedule, such as the ARIC study analyse in this paper, such ad-
ditional model complexity is unlikely to be warranted. We therefore leave this investigation
for future research.
Results from our simulation studies suggest that the best model giving the least bias and
coverage closest to nominal levels is the joint model which allows for correlation between the
SBP usual level and the SBP variability. The naive method gives considerable bias in the
association between SBP variability and CVD, as expected. Results previously reported in
the CVD literature using the naive method could be subject to considerable bias in both
the estimated association and its standard error. Our simulation results also indicate there
may be a complex interplay between different sources of bias. While the use of mixed effects
models and joint models can reduce regression dilution bias, model misspecification, such as
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not accounting for correlation between these variables, may introduce additional sources of
bias.
Our analyses of the ARIC data found evidence of a positive association between higher
SBP variability and the risk of CVD events. For this dataset results between the two-stage
LMM approach and the joint modelling approach were similar, suggesting that the biases
incurred by use of the two-stage approach were minimal in this example. However, use of
the joint model comes at a cost of considerably longer computational time. This might be
reduced by running multiple MCMC chains in parallel. If computational time is an issue
then a possible modelling strategy would be to use the two-stage method for model selection
and the joint model for inference. If there was also clinical interest in identifying explanatory
variables associated with the longitudinal variability then the mixed effects models could be
extended to incorporate a linear predictor in the mean of the log σi distribution, µσ,i = ζ
TXσi .
Similar models have previously been considered by Hedeker et al[6, 7] and Goldstein et al[4].
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1 Bias caused by ignoring correlations in linear regres-
sion
Consider a linear regression of outcome y on correlated covariates x1 and x2,
y = β1x1 + β2x2 + ε ,
where ε ∼ N(0, σ2y) is the residual error in y. Now let
x1 = ρ
σ1
σ2
x2 + λ ,
where λ and x2 are uncorrelated, Var(x1) = σ
2
1, Var(x2) = σ
2
2 and ρ is the correlation between
x1 and x2. Re-writing the linear predictor,
y = β1λ+
(
ρ
σ1
σ2
β1 + β2
)
x2 .
As λ and x2 are uncorrelated we find
βˆ2 =
Cov(y, x2)
σ22
− ρβˆ1σ1
σ2
(7)
If x1 and x2 are estimated ignoring the correlation between them, effectively setting ρ = 0,
we would therefore expect to observe a positive bias in βˆ2 when ρ and βˆ1 are both positive,
because the second term in equation (7) is ignored. By symmetry, we would also expect to
observe a positive bias in βˆ1 for positive ρ and positive βˆ2.
2 Additional simulation studies
In this section we present the results of further simulation studies investigating performance
of the models for different levels of association between the longitudinal trajectories and the
CVD event and for different levels of correlation between the usual level and the variability
for Scenario 1.
Table 5 shows results for different values of the true logHR’s α0 and ασ. All results are
given for datasets with n = 4 measurements per individual. When ασ = 0, i.e. there is no
association between the longitudinal variability and the time-to-event, the naive method has
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negative bias in the usual level logHR due to regression dilution, but there is no bias in the
variability logHR. By contrast, for methods LMM1 and JM1 there is slight positive bias in
the variability logHR because the correlation between the usual level and the variability has
been ignored. In this case, therefore, using the mixed effects model may lead to increased bias
compared to the naive method because the model is misspecified. Results for larger values of
the logHRs show substantial bias in both logHRs for the naive and LMM methods, with the
naive method performing the worst. The joint models give little bias in the logHR for the
usual level, but some negative bias for the variability logHR. Coverage probabilities are very
much lower than the nominal 95% level, with those of the joint models being substantially
closer than all other methods. These results suggest that for substantially larger effect
sizes, or equivalently for substantially less variation in the usual levels or variabilities in
the population, all methods require a greater number of measurements per individual to
sufficiently reduce estimation bias.
Results for various values of the correlation parameter ρ are shown in Table 6. Again, each
individual has n = 4 measurements. When there is negative correlation we find negative bias
in both association parameters for the naive, LMM1 and JM1 methods, as we would expect
from the arguments given in Section 1. Bias in the usual level logHR using the methods
LMM1 and JM1, which ignore the correlation, increases with increasing ρ. But for the
variability logHR the pattern is less clear because of the interplay between regression dilution
bias and the bias incurred by ignoring correlation in the mixed effects model. For models
LMM2 and JM2, which account for the correlation, we found minimal bias in estimated
effects and coverage close to nominal values in all cases.
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Table 5: Scenario 1 results with different levels of association between the usual level and the variability of
the longitudinal outcome and the time-to-event. Presented are the true values, mean (standard deviation) of
estimated log hazard ratios, root mean squared error and coverage over 1000 simulated datasets. Methods
of analysis are (1) True values, where the true usual levels and variabilities are used as covariates, (2) Naive
method, (3) LMM1, the two-stage approach with no correlation between the usual level and the variability,
(4) LMM2, the two-stage approach with correlation, (5) JM1, the joint model with no correlation and (6)
JM2, the joint model with correlation.
Usual level logHR α0 Variability logHR ασ
True Mean (SD) RMSE Coverage True Mean (SD) RMSE Coverage
α0 = 0.02, ασ = 0
True values 0.02 0.0201 (0.0043) 0.0043 0.949 0 -0.0011 (0.0138) 0.0139 0.955
Naive 0.02 0.0175 (0.0038) 0.0045 0.893 0 0.0012 (0.0103) 0.0103 0.946
LMM1 0.02 0.0193 (0.0042) 0.0043 0.943 0 0.0062 (0.0165) 0.0176 0.935
LMM2 0.02 0.0199 (0.005) 0.005 0.944 0 -1e-04 (0.0192) 0.0192 0.953
JM1 0.02 0.0194 (0.0042) 0.0043 0.942 0 0.0043 (0.017) 0.0175 0.943
JM2 0.02 0.0201 (0.0051) 0.0051 0.944 0 -0.0024 (0.0198) 0.0199 0.956
α0 = 0.02, ασ = 0.05
True values 0.02 0.02 (0.0043) 0.0043 0.94 0.05 0.0501 (0.0117) 0.0117 0.94
Naive 0.02 0.0208 (0.0037) 0.0038 0.947 0.05 0.0284 (0.0094) 0.0235 0.31
LMM1 0.02 0.0227 (0.0042) 0.005 0.892 0.05 0.0531 (0.0151) 0.0154 0.929
LMM2 0.02 0.0198 (0.0049) 0.0049 0.948 0.05 0.0511 (0.0175) 0.0175 0.931
JM1 0.02 0.023 (0.0042) 0.0052 0.883 0.05 0.0521 (0.0155) 0.0156 0.939
JM2 0.02 0.02 (0.0051) 0.0051 0.949 0.05 0.0502 (0.0183) 0.0183 0.936
α0 = 0.05, ασ = 0.02
True values 0.05 0.0502 (0.0043) 0.0043 0.948 0.02 0.0201 (0.0112) 0.0112 0.942
Naive 0.05 0.044 (0.0037) 0.007 0.6 0.02 0.0125 (0.009) 0.0117 0.834
LMM1 0.05 0.0491 (0.0041) 0.0042 0.94 0.02 0.036 (0.0139) 0.0212 0.767
LMM2 0.05 0.0495 (0.0049) 0.0049 0.94 0.02 0.0216 (0.0161) 0.0161 0.944
JM1 0.05 0.0501 (0.0043) 0.0043 0.946 0.02 0.0339 (0.0145) 0.02 0.843
JM2 0.05 0.0505 (0.0051) 0.0051 0.945 0.02 0.0193 (0.0168) 0.0168 0.952
α0 = 0.1, ασ = 0.25
True values 0.1 0.1002 (0.0043) 0.0043 0.94 0.25 0.251 (0.0106) 0.0106 0.952
Naive 0.1 0.082 (0.004) 0.0184 0.002 0.25 0.0972 (0.0097) 0.1531 0
LMM1 0.1 0.0911 (0.0043) 0.0099 0.386 0.25 0.1879 (0.0152) 0.0639 0.008
LMM2 0.1 0.0818 (0.0048) 0.0188 0.027 0.25 0.1759 (0.0183) 0.0763 0.007
JM1 0.1 0.1081 (0.0055) 0.0098 0.695 0.25 0.2191 (0.0191) 0.0363 0.589
JM2 0.1 0.0969 (0.0057) 0.0065 0.905 0.25 0.2096 (0.0215) 0.0458 0.503
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Table 6: Scenario 1 results with different levels of correlation between the usual level and the variability of
the longitudinal outcome. Presented are the true values, mean (standard deviation) of estimated log hazard
ratios, root mean squared error and coverage over 1000 simulated datasets. Methods of analysis are (1) True
values, where the true usual levels and variabilities are used as covariates, (2) Naive method, (3) LMM1, the
two-stage approach with no correlation between the usual level and the variability, (4) LMM2, the two-stage
approach with correlation, (5) JM1, the joint model with no correlation and (6) JM2, the joint model with
correlation.
Usual level logHR α0 Variability logHR ασ
True Mean (SD) RMSE Coverage True Mean (SD) RMSE Coverage
ρ = −0.5
True values 0.02 0.02 (0.0043) 0.0043 0.939 0.05 0.0497 (0.0127) 0.0127 0.957
Naive 0.02 0.0148 (0.0038) 0.0064 0.739 0.05 0.025 (0.01) 0.0269 0.255
LMM1 0.02 0.0165 (0.0042) 0.0055 0.883 0.05 0.0399 (0.0163) 0.0192 0.916
LMM2 0.02 0.0199 (0.0048) 0.0048 0.94 0.05 0.0507 (0.019) 0.019 0.951
JM1 0.02 0.0167 (0.0043) 0.0054 0.894 0.05 0.0382 (0.0164) 0.0202 0.898
JM2 0.02 0.0201 (0.005) 0.005 0.937 0.05 0.0493 (0.0192) 0.0192 0.955
ρ = 0
True values 0.02 0.0198 (0.0038) 0.0038 0.946 0.05 0.0496 (0.0105) 0.0105 0.951
Naive 0.02 0.0177 (0.0036) 0.0042 0.892 0.05 0.0293 (0.0087) 0.0224 0.309
LMM1 0.02 0.0196 (0.0039) 0.004 0.945 0.05 0.0509 (0.0147) 0.0148 0.947
LMM2 0.02 0.0196 (0.0039) 0.004 0.946 0.05 0.0509 (0.0148) 0.0148 0.94
JM1 0.02 0.0199 (0.004) 0.004 0.943 0.05 0.0496 (0.015) 0.015 0.955
JM2 0.02 0.0199 (0.004) 0.004 0.941 0.05 0.0497 (0.015) 0.015 0.949
ρ = 0.2
True values 0.02 0.0201 (0.0037) 0.0037 0.95 0.05 0.0501 (0.0105) 0.0105 0.959
Naive 0.02 0.0191 (0.0035) 0.0036 0.949 0.05 0.0294 (0.0088) 0.0224 0.32
LMM1 0.02 0.021 (0.0039) 0.004 0.949 0.05 0.0525 (0.0147) 0.0149 0.935
LMM2 0.02 0.02 (0.004) 0.004 0.954 0.05 0.0509 (0.0151) 0.0151 0.939
JM1 0.02 0.0213 (0.0039) 0.0042 0.945 0.05 0.0514 (0.0151) 0.0152 0.94
JM2 0.02 0.0202 (0.004) 0.004 0.956 0.05 0.0497 (0.0154) 0.0154 0.949
ρ = 0.5
True values 0.02 0.02 (0.0043) 0.0043 0.94 0.05 0.0501 (0.0117) 0.0117 0.94
Naive 0.02 0.0208 (0.0037) 0.0038 0.947 0.05 0.0284 (0.0094) 0.0235 0.31
LMM1 0.02 0.0227 (0.0042) 0.005 0.892 0.05 0.0531 (0.0151) 0.0154 0.929
LMM2 0.02 0.0198 (0.0049) 0.0049 0.948 0.05 0.0511 (0.0175) 0.0175 0.931
JM1 0.02 0.023 (0.0042) 0.0052 0.883 0.05 0.0521 (0.0155) 0.0156 0.939
JM2 0.02 0.02 (0.0051) 0.0051 0.949 0.05 0.0502 (0.0183) 0.0183 0.936
ρ = 0.8
True values 0.02 0.0201 (0.0055) 0.0055 0.959 0.05 0.0503 (0.015) 0.015 0.955
Naive 0.02 0.0237 (0.0041) 0.0055 0.831 0.05 0.0242 (0.0098) 0.0276 0.217
LMM1 0.02 0.0256 (0.0046) 0.0073 0.767 0.05 0.0495 (0.015) 0.015 0.948
LMM2 0.02 0.0202 (0.0077) 0.0077 0.951 0.05 0.0506 (0.0245) 0.0245 0.946
JM1 0.02 0.0259 (0.0047) 0.0075 0.749 0.05 0.0485 (0.0154) 0.0155 0.953
JM2 0.02 0.02 (0.008) 0.008 0.949 0.05 0.051 (0.026) 0.026 0.946
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3 ARIC study baseline characteristics
Table 7 shows baseline characteristics of individuals in the reduced and full ARIC datasets
at the study baseline. The age and cholesterol levels are similar between the two datasets,
but the reduced dataset has a lower proportion of males, smokers and diabetics than the full
dataset.
Table 7: Baseline characteristics of individuals in the reduced and full ARIC datasets; mean
(SD) unless stated otherwise.
Reduced dataset Full dataset
n = 10,019 n = 13,161
Age, years 54.1 (5.7) 54.4 (5.7)
Sex (male), n (%) 4286 (42.8) 5924 (45.0)
Total cholesterol, mmol/L 5.5 (1.0) 5.5 (1.1)
HDL cholesterol, mmol/L 1.4 (0.4) 1.4 (0.4)
Smoker, n(%) 2372 (23.7) 3671 (27.9)
Diabetic, n(%) 817 (8.2) 1407 (10.7)
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